TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novel Medic AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,103
|
3,837
|
3,135 |
| Financial expenses |
0
|
3
|
4 |
| Earnings before taxes |
865
|
2,344
|
1,596 |
| EBITDA |
1,005
|
2,410
|
1,654 |
| Total assets |
3,760
|
3,401
|
2,080 |
| Current assets |
2,973
|
2,732
|
1,893 |
| Current liabilities |
332
|
459
|
672 |
| Equity capital |
3,259
|
2,814
|
1,281 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
13
|
14
|
10 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
86.7%
|
82.7%
|
61.6% |
| Turnover per employee |
239
|
274
|
314 |
| Profit as a percentage of turnover |
27.9%
|
61.1%
|
50.9% |
| Return on assets (ROA) |
23.0%
|
69.0%
|
76.9% |
| Current ratio |
895.5%
|
595.2%
|
281.7% |
| Return on equity (ROE) |
26.5%
|
83.3%
|
124.6% |
| Change turnover |
-745
|
956
|
2,134 |
| Change turnover % |
-19%
|
33%
|
213% |
| Chg. No. of employees |
-1
|
4
|
5 |
| Chg. No. of employees % |
-7%
|
40%
|
100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.